The supply flow of an FDA-approved cardiovascular device was under threat. The polyester yarn used in the device had been discontinued, and the manufacturer that supplied the woven textile component could no longer dedicate resources to investigating a replacement yarn.
As device inventory dwindled, the original equipment manufacturer needed to find a partner capable of creating a replica yarn and woven textile that closely matched the physical properties of the original components. Failing that, the company risked having to make drastic changes to the device to appease regulatory requirements, further increasing the possibility of a disruption in supply.
Read how Secant successfully reverse-engineered the woven textile component based on the original sample to help the medical equipment manufacturer avoid sales disruption.